tirzepatide and alcohol consumption attenuates dopamine reward signaling suppresses drinking and relapse-like behaviors in rodents Tirzepatide reduces alcohol drinking and

Short peptide sequences: current knowledge and future prospects

This cutting-edge treatment uses pharmacy-grade injections to target and eliminate stubborn fat that is resistant to diet and exercise

Tirzepatide, a dual GLP-1 and GIP receptor agonist, has demonstrated weight loss of 20-22% in clinical trials when combined with lifestyle modification

This imbalance can disrupt the HPG axis short for the hypothalamic-pituitary-gonadal axis which links the brain and testes to regulate testosterone levels and sperm production

PlexusDx offers the Microdose GLP-1 Protocol starting at $129 per month as an alternative entry point for patients who need a gentler introduction to GLP-1 therapy

Pricing starts at $249 per month